What are the testicles? 

The testicles, or testes, are two oval-shaped organs located in the scrotum, which is a skin sac beneath the penis. They are part of the male reproductive system and have two main functions: producing sperm, which is necessary for reproduction, and producing testosterone, the primary male sex hormone that regulates various functions including muscle mass, bone density, and sex drive. 

What is testicular cancer? 

Testicular cancer is a type of cancer that develops in the testicles (testes), which are part of the male  reproductive system. The testicles are responsible for producing sperm and the hormone testosterone.  Testicular cancer occurs when abnormal cells in the testicles grow uncontrollably, forming a tumor. 

Types of Testicular Cancer 

There are two main types of testicular cancer: 

  • Seminomas: Seminomas are composed of a single type of cancer cell that originates from a gonadal stem cell. These tumors grow slowly and are usually sensitive to radiation therapy. They tend to occur in men aged 30 to 50. 
  • Non-seminomas: Generally, consist of a variety of cell types, including teratoma, embryonal carcinoma, choriocarcinoma, and yolk sac tumors. This group includes different types of tumors that tend to grow more rapidly and may require different treatment approaches. They commonly occur in younger men, typically in their late teens to early 30s.

What signs and symptoms should I look for in testicular cancer? 

Common symptoms of testicular cancer include: 

• A lump or swelling in one or both testicles. 

• A feeling of heaviness in the scrotum. 

• A dull ache or pain in the lower abdomen or groin. 

• A sudden collection of fluid in the scrotum. 

• Pain or discomfort in a testicle or the scrotum. 

If the cancer has spread to the lymph nodes in the back of the abdomen, it could cause back pain or  discomfort in the lower abdomen. Additionally, if the cancer has metastasized to other areas like the  lungs, pelvis, or brain, symptoms in those regions may also appear.

How prevalent is testicular cancer? 

Testicular cancer is relatively uncommon in India compared to Western countries. According to the  Indian Council of Medical Research (ICMR), the incidence rate of testicular cancer in India is estimated  to be around 0.9 to 1.0 per 100,000 men.  

Source: ESMO

What leads to the development of testicular cancer? 

Cryptorchidism: Also known as undescended testicles. 

Klinefelter’s Syndrome: A genetic condition characterized by an extra X chromosome in males. 

Family History: Having relatives with testicular cancer. 

Male Infertility: Associated with a threefold increase in risk. 

Birth and Maternal Factors: Includes low birth weight, young maternal age, young paternal age, multiple births, and breech delivery. 

Infantile Hernia: Presence of hernias during infancy. 

Height: Taller men have a higher risk of developing germ cell tumors. 

Among these factors, cryptorchidism and the presence of cancer in the other testicle are the most  significant risk factors for developing testicular germ cell tumors. Testicular microlithiasis, vasectomy,  and scrotal trauma are not considered risk factors for testicular cancer. 

What methods are used to diagnose testicular cancer? 

Diagnosing testicular cancer involves several methods to confirm the presence and extent of the  disease. The key diagnostic approaches include: 

Physical Examination: 

Scrotal Examination: The doctor performs a physical exam to check for any lumps,  swelling, or abnormalities in the testicles and scrotum. 

Ultrasound

  • Scrotal Ultrasound: An imaging test that uses sound waves to create detailed images of the  testicles. It helps to distinguish between solid tumors and fluid-filled cysts and provides  information about the size and location of any abnormalities. 

Blood Tests:

  • Tumor Markers: Blood tests measure levels of certain substances produced by cancer cells.  Common tumor markers for testicular cancer include:
  • Alpha-fetoprotein (AFP) 
  • Human chorionic gonadotropin (hCG) 
  • Lactate dehydrogenase (LDH)** 

 Elevated levels of these markers can indicate the presence of  testicular cancer. 

Imaging Tests: 

  • CT scan: A computed tomography scan of the abdomen and pelvis to check for cancer spread to lymph nodes or other organs. 
  • Chest X-ray: To examine the lungs and check for possible spread of cancer. 

Biopsy: 

  • Testicular Biopsy: Generally avoided because it can increase the risk of cancer spreading.  Instead, a surgical procedure called orchidectomy (removal of the affected testicle) is  often used to both diagnose and treat the cancer. 

Surgical Exploration: 

  • Orchidectomy: The removal of the testicle for examination by a pathologist to confirm the presence of cancer and determine its type.

How will my treatment plan be determined? 

Staging:  

  • Staging is the process used to describe the size, location, and spread of cancer from its  original site. For testicular cancer, staging typically involves examining the removed tissue,  conducting a computed tomography (CT) scan, and measuring blood levels of tumor  markers such as AFP, HCG, and LDH.  
  • A CT scan, which is a specialized x-ray technique, provides detailed cross-sectional  images of internal organs. If you are diagnosed with testicular cancer, a CT scan of the  abdomen and pelvis is commonly performed to determine if the cancer has spread.  Additionally, a CT scan of the lungs may be conducted. 
  • In cases of advanced testicular cancer, an MRI scan of the central nervous system may be  used to check for possible brain metastases. 
Source: ESMO
Source: ESMO

What treatment options are available for seminoma? 

Treatment options for seminoma, a type of testicular cancer, depend on the stage of the cancer and the  individual’s overall health. The primary treatment options include: 

Surgery: 

Orchidectomy: The surgical removal of the affected testicle is usually the first step in treating seminoma. This procedure helps to both diagnose and treat the cancer. 

Radiation Therapy:

  • Adjuvant Radiation: For early-stage seminoma (stage I), radiation therapy to the abdominal lymph  nodes is often used after surgery to kill any  remaining cancer cells and reduce the risk of recurrence. 
  • Primary Treatment: In some cases, radiation may be used as the main treatment, especially if the cancer is confined to the testicle and has  not spread beyond the lymph nodes. 

Chemotherapy: 

  • Adjuvant Chemotherapy: For higher stages of  seminoma (such as stage II or III), chemotherapy may be recommended after surgery and radiation to target and eliminate any cancer cells that may have spread beyond the testicle. 
  • Primary Treatment: In cases where seminoma has spread extensively or has relapsed,  chemotherapy can be used as a primary treatment approach. 

Surveillance: 

  • Active Surveillance: For early-stage seminoma with a low risk of recurrence, active  surveillance might be recommended. This involves regular monitoring through physical  exams, blood tests, and imaging studies to detect any signs of cancer returning.

Combination Therapy: 

In some cases, a combination of surgery, radiation therapy, and chemotherapy may be  used to effectively treat seminoma, depending on the stage and extent of the disease.

The choice of treatment will be tailored to the individual’s specific condition, considering the cancer  stage, overall health, and personal preferences. It’s important to discuss all available options with a  healthcare provider to determine the best approach for managing seminoma. 

What are the treatment options for non-seminoma? 

Treatment options for non-seminoma, a type of testicular cancer, vary depending on the stage and extent  of the disease. The main treatment approaches include: 

Surgery: 

Orchidectomy: The primary treatment for non-seminoma is the surgical removal of the  affected testicle (orchidectomy). This procedure not only helps in diagnosing the cancer  but also removes the primary tumor. 

Chemotherapy: 

  • Adjuvant Chemotherapy: For non-seminomas that are diagnosed at a higher stage (such  as stage II or III) or have a high risk of recurrence, chemotherapy is used to target cancer  cells that may have spread beyond the testicle. Common regimens include combinations  of cisplatin, etoposide, and bleomycin. 
  • Primary Treatment: If the cancer is advanced or has relapsed, chemotherapy can be used  as the main treatment to address cancer that has spread to other parts of the body.

Radiation Therapy: 

Radiation therapy is less commonly used for non-seminomas compared to seminomas. However, it might be used in specific cases where there is localized  spread to lymph nodes or other areas, but this is less common. 

Surveillance:

  • Active Surveillance: For early-stage non-seminoma with a low risk of recurrence,  close monitoring through regular physical exams, blood tests, and imaging studies  may be recommended to detect any signs of recurrence. 

Combination Therapy: 

In some cases, a combination of surgery, chemotherapy, and possibly radiation  therapy may be used, depending on the stage and spread of the cancer. 

Salvage Therapy: 

For non-seminomas that are resistant to initial treatments or have relapsed, salvage  chemotherapy or high-dose chemotherapy followed by stem cell transplantation may  be considered. 

What treatments are available if testicular cancer recurs  after initial therapy? 

Seminoma: 

  • Stage II Seminomas: Typically treated with adjuvant therapy, which may include radiotherapy or cisplatin based chemotherapy, often combined with etoposide. 
  • Stage IIC and IID Seminomas: Initial treatment usually involves chemotherapy. 
  • Stage III and IV Seminomas: Generally managed with cisplatin-based chemotherapy.  Carboplatin may be used as a substitute for cisplatin only in rare cases. 

Non-Seminomatous Germ Cell Tumors (NSGCT):

  • Good-Prognosis Metastatic NSGCT: Recommended treatment is three cycles of BEP  chemotherapy. The International Germ Cell Consensus Classification (IGCCC) determines  prognosis based on the primary site, presence of non-pulmonary metastases, and tumor marker  levels. 
  • Good-Prognosis Metastatic NSGCT with Bleomycin Contraindication: Should receive  chemotherapy with etoposide and cisplatin instead. 
  • Intermediate and Poor-Risk Germ Cell Tumors: Standard initial treatment involves four cycles  of BEP chemotherapy. 

What potential side effects can arise from treatment? 

  • Most individuals who survive testicular cancer return to a normal quality of life. However, some  may experience hypogonadism following orchidectomy, and fertility can be compromised after  chemotherapy.  
  • Side effects from chemotherapy, such as peripheral neuropathy, Raynaud’s phenomenon, and  hearing loss, may persist for years.  
  • There is a 2.0- to 3.7-fold increased risk of developing cancers of the small intestine, bladder,  kidney, and lung after chemotherapy. Additionally, survivors face a higher risk of cardiovascular  events, similar to the risks associated with long-term smoking. 
  • While overall quality of life scores are comparable to those of the general population, survivors  may experience anxiety related to recurrence fears, financial concerns, alcohol misuse, and  sexual difficulties.  
  • Late relapse, characterized by new tumor growth more than two years after completing at least  three cycles of chemotherapy, occurs in 2-3% of cases and generally responds poorly to further  chemotherapy.

How does testicular cancer treatment impact fertility?

Testicular cancer treatment can impact fertility in several ways: 

Surgery: 

  • Orchidectomy: The removal of one testicle can affect fertility, though many men retain  normal fertility with the remaining testicle. However, if the remaining testicle is affected  or if additional factors are present, fertility may be compromised. 

Chemotherapy: 

  • Impact on Sperm Production: Chemotherapy drugs can damage the testicular tissue  responsible for sperm production, leading to reduced sperm count or temporary  infertility. The extent of this effect varies depending on the drugs used, dosage, and  duration of treatment.
  • Recovery: Fertility may return after chemotherapy, but this can take several months to  years. In some cases, permanent infertility can occur. 

Radiation Therapy: 

  • Effect on Sperm Production: Radiation therapy, especially if directed at the pelvic area, can damage the testicular tissue and affect sperm production. This can lead to temporary or permanent infertility, depending  on the dose and area treated. 

Hormonal Changes: 

  • Impact on Hormones: Some treatments can affect hormone levels, which may  influence fertility and sexual function. 

Fertility Preservation: Before starting treatment, patients are often advised to consider sperm banking  (cryopreservation) to preserve fertility for future use. 

What is the prognosis for testicular cancer? 

Prognosis:  

o Mortality rates have decreased in Western countries, with prognosis varying based on the  stage of cancer, tumor type, and levels of tumor markers (low, medium, or high). Early  diagnosis significantly improves outcomes, with over 95% of men being cured and  potentially requiring less intensive treatment. Non-seminomatous germ cell tumors  (NSGCTs) generally have less favorable outcomes compared to seminomas.  

Choriocarcinomas have the poorest prognosis among testicular cancers.